You Are Here    News

News
EASL issues new hepatitis C treatment recommendations for all genotypes
by Liz Highleyman, 2016-09-26 11:40
The European Association for the Study of the Liver (EASL) released its latest recommendations on treatment of hepatitis C at a special meeting last Thursday in Paris. The updated guidelines now include highly effective interferon-free options for all hepatitis C virus (HCV) genotypes and for the most challenging patients. EASL usually releases revised recommendations at its

Structural inequalities create vulnerability to HIV for black gay men in New York
by Roger Pebody, 2016-09-23 11:00
The sexual relationships of many African American men who have sex with men are largely shaped by economic insecurity, housing instability and stigma, according to a new study. These structural inequalities influence the kinds of relationships and sexual behaviour that men have.While most HIV prevention interventions and studies focus on the individual, “our research

Early infant HIV testing at birth and at 6 weeks of age will save lives, extend life expectancy and is cost effective for South Africa, study finds
by Michael Carter, 2016-09-22 09:30
Early infant HIV diagnosis in South Africa will save lives, extend life expectancy and be cost effective, according to a modelling study published in the online edition of the Journal of Infectious Diseases. Compared to no early infant diagnosis (EID), testing at either birth or six weeks of life reduced one-year mortality rates, led to

Early infant HIV testing at birth and at 6 weeks of age will save lives, extend life expectancy and is cost-effective for South Africa, study finds
by Michael Carter, 2016-09-22 09:30
Early infant HIV diagnosis in South Africa will save lives, extend life expectancy and be cost-effective, according to a modelling study published in the online edition of the Journal of Infectious Diseases. Compared to no early infant diagnosis (EID), testing at either birth or 6 weeks of life reduced one-year mortality rates, led to

Spanish study gives reassurance: small HIV blips do not predict treatment failure
by Michael Carter, 2016-09-21 08:10
A very low viral load (20-49 copies/ml) during HIV therapy does not increase the risk of the subsequent virological failure of treatment (viral load above 200 copies/ml), according to Spanish research published in HIV Medicine. The findings of the study will provide reassurance that patients with very low level viraemia (VLLV) do not need to change